A Survey of Korean Physicians’ Prescription Patterns for Allergic Rhinitis
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objectives. The aim of this study was to compare the prescription patterns according to characteristics of physicians using a survey distributed amongst physicians in Korea. Methods. We surveyed the prescription patterns for allergic rhinitis (AR) of the members of the Korean Academy of Asthma, Allergy and Clinical Immunology (KAAACI) and the Korean Association of Otorhinolaryngologists (KAO). Questionnaire contained 4 categories with 28 queries. 448 physicians including 98 internal medicine (IM), 113 pediatrics (PED), and 237 otorhinolaryngology (ENT) were responded. Results. Although the Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines are most frequently used in all specialties, seasonal or perennial AR is the most frequent classification system. For the definitive diagnosis of AR, ENT physicians reported using multiple allergen simultaneous test (MAST)/radio allergy sorbent test (RAST) more than others (IM, 10.9%; PED, 20.6%; ENT, 44.2%; P<0.001). In treatment, most physicians reported that antihistamine medication is the initial treatment for AR. PED physicians prescribed fewer intranasal steroid to combinations with an antihistamine than other specialists (IM, 65.3%; PED, 42.5%; ENT, 63.3%), but preferred leukotriene antagonists (IM, 4.1%; PED, 23.0%; ENT, 3.9%; P=0.041). Overall, 53% (235/448) of the physicians performed allergen immunotherapy (AIT), and IM administers the most AIT (IM, 71.6%; PED, 42.0%; ENT, 39.5%; P=0.019). Furthermore, university and general hospital physicians prescribed more AIT than doctors at other hospital types (university hospital, 76.4%; general hospital, 64.3%; local hospital, 21.4%; private clinic, 20.2%; P<0.001). Conclusion. The prescription patterns for AR were different according to the physicians’ characteristics and general rate of prescribing AIT is just about 53% in Korea. Thus, the development of complementary Korean-specific guidelines is needed and proper clinical instruction of AIT would be necessary.
Abstract
Objectives. The aim of this study was to compare the prescription patterns according to characteristics of physicians using a survey distributed amongst physicians in Korea. Methods. We surveyed the prescription patterns for allergic rhinitis (AR) of the members of the Korean Academy of Asthma, Allergy and Clinical Immunology (KAAACI) and the Korean Association of Otorhinolaryngologists (KAO). Questionnaire contained 4 categories with 28 queries. 448 physicians including 98 internal medicine (IM), 113 pediatrics (PED), and 237 otorhinolaryngology (ENT) were responded. Results. Although the Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines are most frequently used in all specialties, seasonal or perennial AR is the most frequent classification system. For the definitive diagnosis of AR, ENT physicians reported using multiple allergen simultaneous test (MAST)/radio allergy sorbent test (RAST) more than others (IM, 10.9%; PED, 20.6%; ENT, 44.2%; P<0.001). In treatment, most physicians reported that antihistamine medication is the initial treatment for AR. PED physicians prescribed fewer intranasal steroid to combinations with an antihistamine than other specialists (IM, 65.3%; PED, 42.5%; ENT, 63.3%), but preferred leukotriene antagonists (IM, 4.1%; PED, 23.0%; ENT, 3.9%; P=0.041). Overall, 53% (235/448) of the physicians performed allergen immunotherapy (AIT), and IM administers the most AIT (IM, 71.6%; PED, 42.0%; ENT, 39.5%; P=0.019). Furthermore, university and general hospital physicians prescribed more AIT than doctors at other hospital types (university hospital, 76.4%; general hospital, 64.3%; local hospital, 21.4%; private clinic, 20.2%; P<0.001). Conclusion. The prescription patterns for AR were different according to the physicians’ characteristics and general rate of prescribing AIT is just about 53% in Korea. Thus, the development of complementary Korean-specific guidelines is needed and proper clinical instruction of AIT would be necessary.
참고문헌 (28)
- Ahn JC, "Prevalence and risk factors of chronic rhinosinusitus, allergic rhinitis, and nasal septal deviation: results of the Korean National Health and Nutrition Survey 2008-2012", JAMA Otolaryngol Head Neck Surg, 142(2), pp.162~167 (2016)
- 조양선, "Prevalence of Otolaryngologic Diseases in South Korea: Data from the Korea National Health and Nutrition Examination Survey 2008", Clinical and Experimental Otorhinolaryngology, 3(4), pp.183~193 (2010), 대한이비인후과학회
- 유광하, "Burden of Respiratory Disease in Korea: An Observational Study on Allergic Rhinitis, Asthma, COPD, and Rhinosinusitis", Allergy, Asthma & Immunology Research, 8(6), pp.527~534 (2016), 대한천식알레르기학회
- Bousquet J, "Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen)", Allergy, 86, pp.8~160 (2008)
- Seidman MD, "Clinical practice guideline: allergic rhinitis", Otolaryngol Head Neck Surg, 152(1 Suppl), pp.S1~S43 (2015)
- Korean Rhinologic Society, "Guidelines for allergic rhinitis", Korean Rhinologic Society, ~ (2012)
- Korean Academy of Asthma, Allergy and Clinical Immunology, "Guidelines for clinicians: allergic rhinitis", Korean Academy of Asthma, Allergy and Clinical Immunology, ~ (2015)
- 허규영, "A Survey of the Prescription Patterns of Allergen Immunotherapy in Korea", Allergy, Asthma & Immunology Research, 5(5), pp.277~282 (2013), 대한천식알레르기학회
- 동헌종, "Classification of Allergic Rhinitis: What is Most Suitable in Korea?", Allergy, Asthma & Immunology Research, 5(2), pp.65~67 (2013), 대한천식알레르기학회
- 이재서, "Current Specific Immunotherapy for Allergic Rhinitis: Perspectives from Otorhinolaryngologists", Allergy, Asthma & Immunology Research, 6(4), pp.273~275 (2014), 대한천식알레르기학회
- Jung YG, "Comparison of the skin-prick test and Phadia ImmunoCAP as tools to diagnose house-dust mite allergy", Am J Rhinol Allergy, 24(3), pp.226~229 (2010)
- Bousquet J, "Comparison between RAST and Pharmacia CAP system: a new automated specific IgE assay", J Allergy Clin Immunol, 85(6), pp.1039~1043 (1990)
- Scolozzi R, "Comparative evaluation of RAST and MAST-CLA for six allergens for the diagnosis of inhalant allergic disease in 232 patients", Clin Exp Allergy, 22(2), pp.227~231 (1992)
- Brozek JL, "Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 revision", J Allergy Clin Immunol, 126(3), pp.466~476 (2010)
- Wheatley LM, "Clinical practice: allergic rhinitis", N Engl J Med, 372(5), pp.456~463 (2015)
- Han Zhou, "Trends in Specific Immunotherapy for Allergic Rhinitis: A Survey of Chinese ENT Specialists", Allergy, Asthma & Immunology Research, 6(4), pp.296~303 (2014), 대한천식알레르기학회
- Lin Z, "The effects of house dust mite sublingual immunotherapy in patients with allergic rhinitis according to duration", Int Forum Allergy Rhinol, 6(1), pp.82~87 (2016)
- Cingi C, "Efficacy of sublingual immunotherapy for house dust mite allergic rhinitis", Eur Arch Otorhinolaryngol, 272(11), pp.3341~3346 (2015)
- Cardona V, "Immunotherapy in allergic rhinitis and lower airway outcomes", Allergy, 72(1), pp.35~42 (2017)
- 김신혜, "Three-Year Follow-up Results of Sublingual Immunotherapy in Patients With Allergic Rhinitis Sensitized to House Dust Mites", Allergy, Asthma & Immunology Research, 7(2), pp.118~123 (2015), 대한천식알레르기학회
- Marogna M, "Passalacqua G. Long-lasting effects of sublingual immunotherapy according to its duration: a 15-year prospective study", J Allergy Clin Immunol, 126(5), pp.969~975 (2010)
- Dretzke J, "Subcutaneous and sublingual immunotherapy for seasonal allergic rhinitis: a systematic review and indirect comparison", J Allergy Clin Immunol, 131(5), pp.1361~1366 (2013)
- Varney VA, "Usefulness of specific immunotherapy in patients with severe perennial allergic rhinitis induced by house dust mite: a double-blind, randomized, placebo-controlled trial", Clin Exp Allergy, 33(8), pp.1076~1082 (2003)
- Jacobsen L, "Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT study", Allergy, 62(8), pp.943~948 (2007)
- 김태범, "흡입 알레르겐에 대한 감작율: 다기관 공동연구", 천식 및 알레르기, 23(3), pp.483~493 (2003), 대한천식알레르기학회
- Calderon MA, "Monoallergen sublingual immunotherapy versus multiallergen subcutaneous immunotherapy for allergic respiratory diseases: a debate during the AAAAI 2013 Annual Meeting in San Antonio, Texas", J Allergy Clin Immunol Pract, 2(2), pp.136~143 (2014)
- Amar SM, "Response to sublingual immunotherapy with grass pollen extract: monotherapy versus combination in a multiallergen extract", J Allergy Clin Immunol, 124(1), pp.150~156 (2009)
- Nelson HS, "Multiallergen immunotherapy for allergic rhinitis and asthma", J Allergy Clin Immunol, 123(4), pp.763~769 (2009)